From Eric Winer, MD
"We are encouraged by the progress we have made, but we also recognize that there is important work ahead," says Eric Winer, MD.
Read article →
Yale Cancer Centerbreakthroughs Autumn 2026
Putting Patients First
Personalized Medicine and Patient-Centered Care
Treatment-Resistant Cancer
New Drug Shows Promise for Treating Advanced Kidney Cancer
A new immune therapy, which releases the immune system’s “brakes,” successfully treats a subset of patients with clear cell renal cell carcinoma.
Lung Cancer: How Tumors Develop and Resist Treatment, and What Comes Next
Why do lung cancer drugs stop working, and why does the immune system miss tumors? Yale’s Katerina Politi is finding answers that could reshape care.
How an Aggressive Brain Tumor Evades Treatment
Researchers identify divergent paths after treatment that help explain why some brain tumors become resistant to treatment.
Breast Cancer Drug Shows Promise for Treatment-Resistant Uterine Cancer
A targeted chemotherapy drug approved for treatment of breast cancer showed clinical benefit in patients with treatment-resistant uterine cancer.
Community Impact
Closer to Free Ride Celebrates a Community United Against Cancer
Explore photos from the 2026 Closer to Free Ride, which brought cyclists and volunteers together to support cancer research and patient care at Yale.
The Class of 1961 and its Ongoing Support for Cancer Research
In 2011, the Yale College Class of 1961 created a fund to raise money for Yale Cancer Center research. It has awarded more than $900,000 in grants to early-career researchers at Yale Cancer Center.
Masthead
Breakthroughs - Autumn 2026
Executive Editor
- Jennifer Torrance
Senior Editor
- Mallory Locklear, PhD
Contributors
- Isabella Backman
- Terence Corcoran
- Peter Jurich
- Freda Kreier
- Mahima Samraik
Yale School of Medicine
- Nancy J. Brown, MD
- Jean and David W. Wallace Dean of Yale School of Medicine and C.N.H. Long Professor of Internal Medicine
- Eric Winer, MD
- Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Alfred Gilman Professor of Pharmacology and Professor of Medicine (Medical Oncology)
- Meghan Fay, MBA
- Associate Vice President for Medical School Development and Alumni Affairs
- Deirdre Branley
- Executive Director of Communications at Yale School of Medicine and Chief Communications Officer of Yale Medicine